The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Subgroup analyses from READY: Real-world data from an Italian compassionate use program (CUP) of avelumab first-line maintenance (1LM) treatment for locally advanced or metastatic urothelial carcinoma (la/mUC).
 
Sergio Bracarda
Travel, Accommodations, Expenses - Bayer Schering Pharma; Merck Serono; MSD Oncology; Pfizer
 
Lorenzo Antonuzzo
Honoraria - Amgen; AstraZeneca; Novartis; Roche
Consulting or Advisory Role - Merck Serono
 
Marco Maruzzo
Consulting or Advisory Role - Astellas Pharma; Bristol-Myers Squibb; Eisai; Exelx; Janssen; Merck Serono; MSD Oncology; Pfizer
Travel, Accommodations, Expenses - Ipsen; Janssen
 
Daniele Santini
No Relationships to Disclose
 
Rosa Tambaro
No Relationships to Disclose
 
Sebastiano Buti
Consulting or Advisory Role - BMS; BMS; Ipsen; Merck/Pfizer; MSD; Pfizer; Pfizer
Speakers' Bureau - BMS; Ipsen; Merck/Pfizer; MSD; Pfizer
Research Funding - Novartis (Inst); Pfizer (Inst)
 
Francesco Carrozza
Speakers' Bureau - Janssen
 
Fabio Calabrò
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; IPSEN,; Merck; Pfizer
Speakers' Bureau - Bristol-Myers Squibb
 
Giuseppe Di Lorenzo
No Relationships to Disclose
 
Giuseppe Fornarini
No Relationships to Disclose
 
Roberto Iacovelli
Honoraria - Astellas Pharma; IPSEN; MSD; Pfizer
Consulting or Advisory Role - AAA/Endocyte/Novartis; Astellas Pharma; Bayer; Eisai; Janssen; Merck; MSD; Novartis; Pfizer; Sanofi
Speakers' Bureau - Ipsen; Janssen; MSD; Pfizer; Sanofi
Research Funding - Bristol-Myers Squibb/Celgene (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Ipsen; Janssen; MSD; Pfizer
 
Daniela Cullurà
No Relationships to Disclose
 
Carlo Messina
Consulting or Advisory Role - Amgen; Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; GlaxoSmithKline; IPSEN,; Janssen; Merck; Merck KGaA
Travel, Accommodations, Expenses - IPSEN,; Janssen; Merck KGaA
 
Linda Cerbone
No Relationships to Disclose
 
Gennaro Fazzi
Employment - Merck KGaA
 
Filippo Venturini
Employment - Merck KGaA; Merck Serono
 
Raffaele Colasanto
Employment - Merck KGaA; Merck Serono
 
Andrea Necchi
Employment - Bayer (I)
Stock and Other Ownership Interests - Bayer (I)
Honoraria - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Foundation Medicine; Janssen; Merck; Roche
Consulting or Advisory Role - AstraZeneca; Basilea Pharmaceutical; Bayer; Bristol-Myers Squibb; Catalym; Clovis Oncology; GlaxoSmithKline; Incyte; Janssen; Merck Sharp & Dohme; Rainier Therapeutics; Roche; Seattle Genetics/Astellas
Research Funding - AstraZeneca (Inst); Gilead Sciences; Ipsen; Merck Sharp & Dohme (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Janssen; Merck Sharp & Dohme; Pfizer; Rainier Therapeutics; Roche
Other Relationship - Bayer (I)
 
Ugo De Giorgi
Consulting or Advisory Role - Amgen; Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Clovis Oncology; Dompé Farmaceutici; Eisai; Ipsen; Janssen; Merck KGaA; MSD; Novartis; Pfizer; PharmaMar
Research Funding - AstraZeneca (Inst); Roche (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - AstraZeneca/Daiichi Sankyo; Ipsen; Pfizer